Aimei Health Technology Q2 EPS $(0.03) Down From $0.07 YoY
Aimei Health Technology (NASDAQ:AFJK) reported quarterly losses of $(0.03) per share. This is a 142.86 percent decrease over earnings of $0.07 per share from the same period last year.
Stocks · News reference
Aimei Health Technology Terminates The Business Combination Agreement With United Hydrogen Group
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Gold Gains Over 1%; PepsiCo Shares Fall After Q2 Results
U.S. stocks higher, Dow gains over 150 points. NASDAQ up 0.84%, S&P 500 up 0.60%. Tech shares jump 1.3%, communication services down 1.7%. PepsiCo falls 5% on earnings miss. VRAX up 260%, FBRX up 42%, RKTO up 36%. AFJK drops 47%, GLOO down 19%, RXT down 23%. Oil down 0.9%, gold up 1.3%, silver up 3.6%, copper up 2.6%. European markets mostly higher, Asian markets mixed. U.S. jobless claims decline to 215,000.
Nasdaq Gains 100 Points; US Initial Jobless Claims Edge Lower
US stocks mixed, Nasdaq up 0.46% as Dow drops 0.06%. Tech shares surge 1.4%, consumer staples fall 1.7%. Initial jobless claims down to 215,000.
AIMEI HEALTH TECHNOLOGY CO., LTD. ANNOUNCES TERMINATION OF BUSINESS COMBINATION AGREEMENT WITH UNITED HYDROGEN GROUP INC.
Aimei Health Technology Co., Ltd. announced the termination of its Business Combination Agreement with United Hydrogen Group Inc. on July 7, 2026, due to failure to close the transaction by the outside date specified in the agreement. The company expressed confidence in identifying future transaction opportunities.